pharma news today glp-1 today obesity drugs october 2025 trends 2025: real-world data, patient outcomes & future therapies Pharma Giants Bet on Next-Generation – GLP-1 Drugs from the Gray

20 Nanxincun, Xiangshan, Beijing 100093, China Tel: +86 10 6283 6133 Fax: +86 10 8259 2636 E-mail: [email protected] Copyright 2022 by the Institute of Botany, the Chinese Academy of Sciences Online ISSN: 1744-7909 Print ISSN: 1672-9072 CN: 11-5067/Q ICP16067583-22

Improved Glycemic Control: GIP receptor activation enhances insulin sensitivity, while glucagon receptor activation promotes fat oxidation, making these agents effective for adolescents with both obesity and insulin resistance

Introduction Managing heart health is a priority for many adults, yet it often feels like a balancing act between numbers, diet, and lifestyle

Backed by promising research, this peptide is drawing attention in Naples and beyond for its ability to help tissues heal more effectively

In fact, cardiovascular disease is the leading cause of death in MASLD patients 3,6